Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity - PubMed (original) (raw)
doi: 10.1086/671270. Epub 2013 Jun 11.
Affiliations
- PMID: 23838221
- DOI: 10.1086/671270
Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity
Mahesh Swaminathan et al. Infect Control Hosp Epidemiol. 2013 Aug.
Abstract
Objective: To describe the epidemiology of carbapenem-resistant Enterobacteriaceae (CRE) carriage and acquisition among hospitalized patients in an area of CRE endemicity.
Design: Cohort study with a nested case-control study.
Setting: Two acute care, academic hospitals in New York City.
Participants: All patients admitted to 7 study units, including intensive care, medical-surgical, and acute rehabilitation units.
Method: Perianal samples were collected from patients at admission and weekly thereafter to detect asymptomatic gastrointestinal carriage of CRE. A nested case-control study was performed to identify factors associated with CRE acquisition. Case patients were those who acquired CRE during a single hospitalization. Control subjects had no microbiologic evidence of CRE and at least 1 negative surveillance sample. Clinical data were abstracted from the medical record.
Results: The prevalence of CRE in the study population was 5.4% (306 of 5,676 patients), and 104 patients met the case definition of acquisition during a single hospital stay. Mechanical ventilation (odds ratio [OR], 11.5), pulmonary disease (OR, 5.2), days of antibiotic therapy (OR, 1.04), and CRE colonization pressure (OR, 1.15) were independently associated with CRE acquisition. Pulsed-field gel electrophoresis analysis identified 87% of tested Klebsiella pneumoniae isolates as sharing related patterns (greater than 78% similarity), which suggests clonal transmission within and between the study hospitals.
Conclusions: Critical illness and underlying medical conditions, CRE colonization pressure, and antimicrobial exposure are important risk factors for CRE acquisition. Adherence to infection control practices and antimicrobial stewardship appear to be critical components of a CRE control program.
Similar articles
- Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak.
Wiener-Well Y, Rudensky B, Yinnon AM, Kopuit P, Schlesinger Y, Broide E, Lachish T, Raveh D. Wiener-Well Y, et al. J Hosp Infect. 2010 Apr;74(4):344-9. doi: 10.1016/j.jhin.2009.07.022. Epub 2009 Sep 26. J Hosp Infect. 2010. PMID: 19783067 - Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel.
Ben-David D, Masarwa S, Navon-Venezia S, Mishali H, Fridental I, Rubinovitch B, Smollan G, Carmeli Y, Schwaber MJ; Israel PACF CRKP (Post-Acute-Care Facility Carbapenem-Resistant Klebsiella pneumoniae) Working Group. Ben-David D, et al. Infect Control Hosp Epidemiol. 2011 Sep;32(9):845-53. doi: 10.1086/661279. Infect Control Hosp Epidemiol. 2011. PMID: 21828964 - [Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains isolated between 2004-2007 in Ankara University Hospital, Turkey].
Us E, Tekeli A, Arikan Akan O, Dolapci I, Sahin F, Karahan ZC. Us E, et al. Mikrobiyol Bul. 2010 Jan;44(1):1-10. Mikrobiyol Bul. 2010. PMID: 20455393 Turkish. - Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review.
Tischendorf J, de Avila RA, Safdar N. Tischendorf J, et al. Am J Infect Control. 2016 May 1;44(5):539-43. doi: 10.1016/j.ajic.2015.12.005. Epub 2016 Feb 15. Am J Infect Control. 2016. PMID: 26899297 Free PMC article. Review. - An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.
Schwaber MJ, Carmeli Y. Schwaber MJ, et al. Clin Infect Dis. 2014 Mar;58(5):697-703. doi: 10.1093/cid/cit795. Epub 2013 Dec 4. Clin Infect Dis. 2014. PMID: 24304707 Review.
Cited by
- Risk Factors for Carbapenemase-Producing Enterobacterales Infection or Colonization in a Korean Intensive Care Unit: A Case-Control Study.
Kim YA, Lee SJ, Park YS, Lee YJ, Yeon JH, Seo YH, Lee K. Kim YA, et al. Antibiotics (Basel). 2020 Oct 8;9(10):680. doi: 10.3390/antibiotics9100680. Antibiotics (Basel). 2020. PMID: 33049912 Free PMC article. - Epidemiology and Risk Factors of Carbapenemase-Producing Enterobacteriaceae Acquisition and Colonization at a Korean Hospital over 1 Year.
Kim HJ, Hyun J, Jeong HS, Lee YK. Kim HJ, et al. Antibiotics (Basel). 2023 Apr 14;12(4):759. doi: 10.3390/antibiotics12040759. Antibiotics (Basel). 2023. PMID: 37107121 Free PMC article. - Demographic, clinical, and outcome characteristics of carbapenem-resistant Enterobacteriaceae over a 10-year period (2010-2020) in Oman.
Khamis F, Al-Zakwani I, Molai M, Mohsin J, Al Dowaiki S, Al Bahrani M, Petersen E. Khamis F, et al. IJID Reg. 2022 Aug 4;4:165-170. doi: 10.1016/j.ijregi.2022.08.001. eCollection 2022 Sep. IJID Reg. 2022. PMID: 36059919 Free PMC article. - Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species.
Mathers AJ, Vegesana K, German-Mesner I, Ainsworth J, Pannone A, Crook DW, Sifri CD, Sheppard A, Stoesser N, Peto T, Walker AS, Eyre DW. Mathers AJ, et al. J Hosp Infect. 2020 Apr;104(4):456-468. doi: 10.1016/j.jhin.2020.01.005. Epub 2020 Jan 10. J Hosp Infect. 2020. PMID: 31931046 Free PMC article. - Carbapenem-resistant Enterobacter cloacae isolates producing KPC-3, North Dakota, USA.
Kiedrowski LM, Guerrero DM, Perez F, Viau RA, Rojas LJ, Mojica MF, Rudin SD, Hujer AM, Marshall SH, Bonomo RA. Kiedrowski LM, et al. Emerg Infect Dis. 2014 Sep;20(9):1583-5. doi: 10.3201/eid2009.140344. Emerg Infect Dis. 2014. PMID: 25153967 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous